Form 4: Elanco Animal Health EVP & CFO Reports Stock Unit Transaction

Elanco Animal Health EVP and CFO, Robert M. VanHimbergen, reported a transaction involving deferred stock units on May 29, 2026.

Summary

• Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer of Elanco Animal Health Inc., filed a Form 4 statement detailing a transaction.
• The transaction involved 8.2608 deferred stock units, which represent the right to receive one share of Elanco common stock or its cash equivalent.
• These deferred stock units are part of the Executive Deferral and Stock Match Plan and are set to settle in cash or shares upon termination of employment or during a specified future year.
• The transaction date was May 29, 2026, and the securities were acquired (A).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine executive compensation transaction rather than a significant strategic or financial event.

Future Outlook

Deferred stock units are set to settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive compensation and potential stock ownership changes within the animal health industry.

Key Dates

Keywords

Form 4, SEC Filing, Elanco Animal Health, Robert M. VanHimbergen, Deferred Stock Units, Executive Compensation, Insider Trading